Secukinumab Effective for Treating Psoriatic ArthritisSecukinumab Effective for Treating Psoriatic Arthritis

The anti-interleukin-17A monoclonal antibody secukinumab improves signs and symptoms in patients with psoriatic arthritis, according to results from Novartis' FUTURE 2 trial. Reuters Health Information
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Source Type: news